Application 022332

Type
NDA
Sponsor
ELI LILLY CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ADCIRCATADALAFILTABLET;ORAL20MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
43353-070ADCIRCATadalafilAphena Pharma Solutions - Tennessee, LLCNDACurrent
43353-070ADCIRCATadalafilAphena Pharma Solutions - Tennessee, LLCNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent
66302-467ADCIRCATadalafilUnited Therapeutics CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64629SUPPL2020-09-21
64580SUPPL2020-09-16
48333SUPPL2017-05-09
48305SUPPL2017-05-09
17253SUPPL2015-04-07
7249SUPPL2015-04-03
17252SUPPL2014-05-02
29608SUPPL2014-04-30
29607SUPPL2013-11-25
38589SUPPL2013-11-22
7248SUPPL2011-02-14
38588SUPPL2011-02-09
21996ORIG2009-08-03
7247ORIG2009-05-29
17251ORIG2009-05-25